Jumawan, Zyra Belle E.

HRN: 28-37-63  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
OXACILLIN 500MG (VIAL)
04/06/2026
04/12/2026
IVT
115mg
Q6
T/C Omphalitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: